Alcon, Johnson and Johnson Services Inc., Bausch & Lomb Inc., ZEISS International, STAAR Surgical, and Morcher GmbH, among others are the key players in the global ocular implants market.
The global ocular implants market is expected to grow at a CAGR of 6% over the forecast period of 2022-2027.
Around 20 million people worldwide have blindness due to cataracts, while around 75 million people suffer from glaucoma. The cases are increasing steadily and have caused worries for the victims. This has led to the adoption of the intraocular lens and glaucoma devices. These factors along with the increasing awareness of these diseases have bolstered the ocular implants market. The market has seen a lot of technical advancements.
The introduction of the PRIMA system, which is a bionic eye, has helped the sufferers and aided the growth of the market. Microinvasive glaucoma devices have been launched recently which has further expanded the market. The prevalence of eye-related disorders in growing and developing countries has posed potential hazards to the populations in the regions is driving the ocular implants industry.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Alcon is a global leader in the eye care industry. The company have provided eye care services for more than 260 million people in over 140 countries each year. Alcon has more than 23,000 employees working for them through innovative products, partnerships with eye care professionals and programs that advance access to quality eye care. The company provides ocular implants under the brand name Acrysof IOL.
|Headquarters:||New Brunswick, New Jersey, United States|
Johnson & Johnson is one of the largest and most widely recognised healthcare companies in the world. The company has expanded their operations now to more than 60 countries across the world. It has 260 companies that employ a total of 1,34,000 people. The company provides implants under the name Johnson and Johnson Vision.
|Headquarters:||Rochester, New York, United States|
Bausch & Lomb Inc. are one of the largest lenses and eye care companies in the world. It has 12000 employees, and its business is spread across over 100 countries. The company provides ocular lenses in four different types – premium, hydrophobic, hydrophilic, and silicon lenses. The core businesses include over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices, and instruments.
ZEISS International develops and distributes products in the field of optics and optoelectronics. With over 32000 employees, ZEISS has 30 production sites, 60 sales and 27 research and development facilities in around 50 countries. The company has 4 different ocular lenses, namely Monofocal, Toric, EDoF, and Multifocal. The Carl Zeiss Foundation, one of the largest foundations in Germany committed to the promotion of science, is the sole owner of the holding company, Carl Zeiss AG.
|Headquarters:||Monrovia, California, United States|
STAAR Surgical has over 30 years of experience in the optics field. The company sells to over 60 countries including the United States, Canada, Japan, Germany, United Kingdom, and Spain. STAAR provides preloaded and collamer ocular lenses. The company offers the EVO Visian implantable Collamer® lenses (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness.
Morcher GmbH specialises in manufacturing eye implants for cataracts. The company also produces capsular tension rings, aniridia implants, and other special implants. Morcher takes pride in the quality of its products, which it makes in Germany. In close collaboration with leading researchers and ophthalmologists, as well as a network of selected specialists, MORCHER® manufactures products, which not only meet the market requirements but are trend-setting creations.
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.